These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 406783)

  • 21. [Localization of a structural locus of alpha-galactosidase on the X chromosome, using the human-hamster cell hybridization method].
    Rebourcet R; Weil D; Van Cong N; Frézal J
    C R Acad Hebd Seances Acad Sci D; 1974 Jun; 278(26):3379-82. PubMed ID: 4212696
    [No Abstract]   [Full Text] [Related]  

  • 22. [Biochemical diagnosis of Anderson-Fabry disease in two brothers].
    Vidershaĭn GIa; Beĭer EM; Mendel'son MM; Livandovskiĭ IuA
    Vopr Med Khim; 1986; 32(5):120-3. PubMed ID: 3095985
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A microtechnique for quantitative measurements of acid hydrolases in fibroblasts. Its application in diagnosis of Fabry disease and enzyme replacement studies.
    Hasholt L; Sørensen SA
    Clin Chim Acta; 1984 Sep; 142(2):257-61. PubMed ID: 6094040
    [No Abstract]   [Full Text] [Related]  

  • 24. The neurological complications of Anderson-Fabry disease (alpha-galactosidase A deficiency)--investigation of symptomatic and presymptomatic patients.
    Morgan SH; Rudge P; Smith SJ; Bronstein AM; Kendall BE; Holly E; Young EP; Crawfurd MD; Bannister R
    Q J Med; 1990 May; 75(277):491-507. PubMed ID: 2167495
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Anderson-Fabry disease.
    Lancet; 1990 Jul; 336(8706):24-5. PubMed ID: 1973214
    [No Abstract]   [Full Text] [Related]  

  • 26. [Fabry's disease: kidney insufficiency in heterozygous patient].
    Pravatà G; Pinto G; Noto G; Aricò M
    G Ital Dermatol Venereol; 1989; 124(11-12):505-9. PubMed ID: 2561653
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Oligosymptomatic cornea verticillata in a heterozygote for Fabry disease: a novel mutation in the alpha-galactosidase gene.
    Kono JO; Podskarbi T; Shin Y; Lanzl I
    Cornea; 2003 Mar; 22(2):175-7. PubMed ID: 12605057
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Linkage relationship of the loci for Anderson--Fabry disease and the Xg blood groups.
    Johnston AW; Sanger R
    Ann Hum Genet; 1981 May; 45(2):155-7. PubMed ID: 6274251
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Genetic inactivation of the alpha-galactosidase locus in carriers of Fabry's disease.
    Romeo G; Migeon BR
    Science; 1970 Oct; 170(3954):180-1. PubMed ID: 5466114
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Alpha-galactosidase in man-Chinese hamster somatic cell hybrids.
    Meera Khan P; Westerveld A; Wurzer-Figurelli EM; Bootsma D
    Birth Defects Orig Artic Ser; 1975; 11(3):205-10. PubMed ID: 812566
    [No Abstract]   [Full Text] [Related]  

  • 31. Relationship between X-inactivation and clinical involvement in Fabry heterozygotes. Eleven novel mutations in the alpha-galactosidase A gene in the Czech and Slovak population.
    Dobrovolny R; Dvorakova L; Ledvinova J; Magage S; Bultas J; Lubanda JC; Elleder M; Karetova D; Pavlikova M; Hrebicek M
    J Mol Med (Berl); 2005 Aug; 83(8):647-54. PubMed ID: 15806320
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Clinical, histopathological, and biochemical findings in Fabry's disease. A case report and family study.
    Savi M; Olivetti G; Neri TM; Curtoni C
    Arch Pathol Lab Med; 1977 Oct; 101(10):536-9. PubMed ID: 199133
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Angiokeratoma corporis diffusum (Fabry's disease). Update. Apropos of 2 cases].
    Larralde de Luna M; García Díaz R; Sánchez G; Ilari R; Pierini AM; Campoy C; Chamoles NH
    Med Cutan Ibero Lat Am; 1985; 13(2):129-40. PubMed ID: 2995736
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Fabry's disease. Apropos of a family].
    Guízar-Vázquez J; Calva-Mercado MP; Rodríguez-Budelli M; Zetina-Rosales ME; García-Escobar BE; González-Noriega A; Salamanca-Gómez F
    Bol Med Hosp Infant Mex; 1985 Aug; 42(8):494-6. PubMed ID: 2996568
    [No Abstract]   [Full Text] [Related]  

  • 35. Electron microscopic observations on cultured fibroblasts from Fabry heterozygotes and hemizygotes.
    Wandall A; Hasholt L; Sørensen SA
    Ultrastruct Pathol; 1982; 3(1):51-8. PubMed ID: 6280349
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Fabry disease: comparison of enzymatic, linkage, and mutation analysis for carrier detection in a family with a novel mutation (30delG).
    Ashton-Prolla P; Ashley GA; Giugliani R; Pires RF; Desnick RJ; Eng CM
    Am J Med Genet; 1999 Jun; 84(5):420-4. PubMed ID: 10360396
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Fabry disease. Classic hemizygote and residual alpha-galactosidase A activity.
    Pravata G; Noto G; Arico M
    Int J Dermatol; 1991 May; 30(5):367-9. PubMed ID: 1648549
    [No Abstract]   [Full Text] [Related]  

  • 38. [Partial deletion of alpha-galactosidase A gene in a Japanese mutant of Fabry disease].
    Sakuraba H; Bishop DF; Suzuki T; Suzuki Y; Desnick RJ
    No To Hattatsu; 1990 May; 22(3):247-52. PubMed ID: 2163664
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Properties of the residual alpha-galactosidase activity in the tissues of a Fabry hemizygote.
    Rietra PJ; Van den Bergh FA; Tager JM
    Clin Chim Acta; 1975 Aug; 62(3):401-13. PubMed ID: 809216
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Fibroblast alpha-galactosidase A activity for identification of Fabry's disease heterozygotes.
    Fensom AH; Benson PF; Grant AR; Jacobs L
    J Inherit Metab Dis; 1980; 2(1):9-12. PubMed ID: 6273649
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.